Croda invests further in Cutitronics

By Deanna Utroske

- Last updated on GMT

© Getty Images / (AndreyPopov)
© Getty Images / (AndreyPopov)
The beauty ingredient maker announced this week that it is putting even more money into Cutitronics, a health tech company that’s developing consumer skin care devices to deliver customized product and to gather data. The companies are at work on a devise that seemingly has the potential to merge clinical and consumer testing into a single enterprise.

Croda first invested in Cutitronics in mid-2017, becoming a minority stakeholder and adding company president of personal care in North America Sandra Breene to the Cutitronics board, as Cosmetics Design reported​ at the time.

“To be part of Cutitronics at such an exciting time in their development is wonderful,” ​says Breene in a press release announcing the additional investment.

“We believe that a novel device such as CutiTron, and the wealth of data around skin care routines and consumer behaviour it will provide, will be invaluable for us in creating innovative, sustainable next generation ingredients for the personal care industry.”

Dollars

Croda has not shared financial details of the partnership but is clear in stating that the company, even after this latest investment, remains a minority shareholder in Cutitronics.

Cutitronics founder and CEO David Heath, does suggest however that the tech maker is now in a better position to realize its objectives:“Today’s announcement marks a milestone in Cutitronics’ journey,” ​says Heath in the press release issued Wednesday.

“We are excited to be able to put real pace behind our ambitious plans to grow our team and develop our suite of technologies.  The support we have received from Croda to date has been invaluable. Continuing this partnership will assist us in progressing our ambitious plans for 2019 and beyond.”

Devices

The next steps for Croda and Cutitronics is a fully realized, customizable commercial device, according to the release. The devise known as a CutiTron is due for updates, compliance testing, and a pilot manufacturing round.

The CutiTron assesses skin care needs, prepares the skin for efficient skin care application, and doses out the recommended product. “CutiTron’s further development follows extensive collaboration with skin and beauty care companies,” ​emphasizes the press release.

---

DeannaUtroske_Editor_CosmeticsDesign

Deanna Utroske, CosmeticsDesign.com Editor, covers beauty business news in the Americas region and publishes the weekly Indie Beauty Profile column, showcasing the inspiring work of entrepreneurs and innovative brands.

Related news

Show more

Related products

show more

Exosomes: Passing Trend or Transformative Reality?

Exosomes: Passing Trend or Transformative Reality?

Content provided by Naolys | 26-Mar-2024 | White Paper

Exosomes, microscopic vesicles naturally present in abundance within Plant Cells, have garnered significant attention within the scientific and cosmetic...

How Nutricosmetics Can Enhance Skin Beauty

How Nutricosmetics Can Enhance Skin Beauty

Content provided by Activ'Inside | 11-Dec-2023 | White Paper

In the ever-evolving realm of nutricosmetics, where inner wellness meets outer beauty, few natural ingredients have captured the spotlight quite like grapes.

Ultimate Antimicrobial Solution for BPC

Ultimate Antimicrobial Solution for BPC

Content provided by Acme-Hardesty Company | 11-Oct-2023 | White Paper

Sharomix™ EG10, a versatile broad-spectrum antimicrobial liquid blend for preserving personal care products, ensures safety at usage levels ranging from...

Acme-Hardesty Expands Product Line into Canada

Acme-Hardesty Expands Product Line into Canada

Content provided by Acme-Hardesty Company | 07-Jul-2023 | Product Brochure

Acme-Hardesty’s latest expansion into Canada includes Resplanta®, Botaneco®, and BYK from our partners Sharon Personal Care and Eckart Effect Pigments...

Related suppliers